Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis : Multidrug-Resistant Pathogens and Antibiotic Strategies
© Copyright: Yonsei University College of Medicine 2020..
PURPOSE: This study investigated multidrug-resistant (MDR) pathogens and antibiotic strategies of culture-positive spontaneous ascitic infection (SAI) in patients with acute decompensated cirrhosis.
MATERIALS AND METHODS: We retrospectively analyzed 432 acute decompensated cirrhotic patients with culture-positive SAI from 11 teaching hospitals in China (January 2012 to May 2018). A Cox proportional hazards model analysis was conducted to identify independent predictors of 28-day mortality.
RESULTS: A total of 455 strains were isolated from 432 ascitic culture samples. Gram-negative bacteria (GNB), gram-positive bacteria (GPB), and fungi caused 52.3, 45.5, and 2.2% of all SAI episodes, respectively. Episodes were classified as nosocomial (41.2%), healthcare-related (34.7%), and community-acquired (24.1%). Escherichia coli (13.4%) and Klebsiella pneumoniae (2.4%) were extended-spectrum β-lactamase producing isolates. The prevalence of methicillin-resistant Staphylococcus aureus was 1.1%. Ceftazidime, cefepime, aztreonam, and amikacin were recommended as first-line antibiotics agents for non-MDR GNB infections; piperacillin/tazobactam and carbapenems for MDR GNB in community-acquired and healthcare-related or nosocomial infections, respectively; and vancomycin or linezolid for GPB infections, regardless of drug-resistance status. Multivariate analysis revealed days of hospital stay before SAI, upper gastrointestinal bleeding, white blood cell count, alanine aminotransferase, serum creatinine concentration, total bilirubin, and international normalized ratio as key independent predictors of 28-day mortality.
CONCLUSION: MDR pathogens and antibiotic strategies were identified in patients with acute decompensated cirrhosis with culture-positive SAI, which may help optimize therapy and improve clinical outcomes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
|---|---|
| Enthalten in: |
Yonsei medical journal - 61(2020), 2 vom: 03. Feb., Seite 145-153 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liu, Jing [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 22.05.2020 Date Revised 22.05.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3349/ymj.2020.61.2.145 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305934546 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305934546 | ||
| 003 | DE-627 | ||
| 005 | 20231225122241.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3349/ymj.2020.61.2.145 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1019.xml |
| 035 | |a (DE-627)NLM305934546 | ||
| 035 | |a (NLM)31997623 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liu, Jing |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis |b Multidrug-Resistant Pathogens and Antibiotic Strategies |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.05.2020 | ||
| 500 | |a Date Revised 22.05.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Copyright: Yonsei University College of Medicine 2020. | ||
| 520 | |a PURPOSE: This study investigated multidrug-resistant (MDR) pathogens and antibiotic strategies of culture-positive spontaneous ascitic infection (SAI) in patients with acute decompensated cirrhosis | ||
| 520 | |a MATERIALS AND METHODS: We retrospectively analyzed 432 acute decompensated cirrhotic patients with culture-positive SAI from 11 teaching hospitals in China (January 2012 to May 2018). A Cox proportional hazards model analysis was conducted to identify independent predictors of 28-day mortality | ||
| 520 | |a RESULTS: A total of 455 strains were isolated from 432 ascitic culture samples. Gram-negative bacteria (GNB), gram-positive bacteria (GPB), and fungi caused 52.3, 45.5, and 2.2% of all SAI episodes, respectively. Episodes were classified as nosocomial (41.2%), healthcare-related (34.7%), and community-acquired (24.1%). Escherichia coli (13.4%) and Klebsiella pneumoniae (2.4%) were extended-spectrum β-lactamase producing isolates. The prevalence of methicillin-resistant Staphylococcus aureus was 1.1%. Ceftazidime, cefepime, aztreonam, and amikacin were recommended as first-line antibiotics agents for non-MDR GNB infections; piperacillin/tazobactam and carbapenems for MDR GNB in community-acquired and healthcare-related or nosocomial infections, respectively; and vancomycin or linezolid for GPB infections, regardless of drug-resistance status. Multivariate analysis revealed days of hospital stay before SAI, upper gastrointestinal bleeding, white blood cell count, alanine aminotransferase, serum creatinine concentration, total bilirubin, and international normalized ratio as key independent predictors of 28-day mortality | ||
| 520 | |a CONCLUSION: MDR pathogens and antibiotic strategies were identified in patients with acute decompensated cirrhosis with culture-positive SAI, which may help optimize therapy and improve clinical outcomes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Spontaneous ascitic infection | |
| 650 | 4 | |a antibiotic strategies | |
| 650 | 4 | |a cirrhosis | |
| 650 | 4 | |a multidrug-resistant | |
| 650 | 4 | |a risk factors | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 700 | 1 | |a Gao, Yanhang |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Xianbo |e verfasserin |4 aut | |
| 700 | 1 | |a Qian, Zhiping |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jinjun |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Yan |e verfasserin |4 aut | |
| 700 | 1 | |a Meng, Zhongji |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Xiaobo |e verfasserin |4 aut | |
| 700 | 1 | |a Deng, Guohong |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Feng |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Zhiguo |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Hai |e verfasserin |4 aut | |
| 700 | 1 | |a Zheng, Xin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Yonsei medical journal |d 1963 |g 61(2020), 2 vom: 03. Feb., Seite 145-153 |w (DE-627)NLM00031269X |x 1976-2437 |7 nnns |
| 773 | 1 | 8 | |g volume:61 |g year:2020 |g number:2 |g day:03 |g month:02 |g pages:145-153 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3349/ymj.2020.61.2.145 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 61 |j 2020 |e 2 |b 03 |c 02 |h 145-153 | ||